A-01 Registration at Hotel Divani Caravel Tuesday 08.00-19.00 |
A-02 Opening Ceremony at the Divani Caravel (Olympia hall) continued with the Cocktail at the hotel's roof garden by the pool Tuesday 19.00-21.00 |
A-03 Registration at Hotel Divani Caravel Wednesday 07:00-08:45 |
A-04 Welcome and Introduction Wednesday 08:45-09:00 |
B-01 Pascal Girard A Semi-mechanistic Model of Lymphocyte Dynamics in Patients with Multiple Sclerosis Treated with Cladribine Tablets Wednesday 09:00-09:20 |
B-06 Mats Karlsson Population Pharmacodynamics of Cladribine Tablets Therapy in Patients with Multiple Sclerosis: Relationship between Magnetic Resonance Imaging and Clinical Outcomes Wednesday 09:20-09:40 |
B-07 Bambang Adiwijaya An integrated, mechanistic model of viral eradication and its clinical applications in treatment regimens with direct-acting antivirals for chronic hepatitis C Wednesday 09:40-10:00 |
B-08 Lutz Harnisch Presentation of DDMoRe Wednesday 10:00-10:15 |
B-09 Coffee break, Poster and Software session I: Posters in Group I (with poster numbers starting with I-) are accompanied by their presenter Wednesday 10:15-11:45 |
B-10 Nick Holford A tutorial on time to event analysis for mixed effect modellers Wednesday 11:45-12:45 |
B-11 Lunch Wednesday 12:45-14:15 |
B-12 Chuanpu Hu Informative Dropout and Visual Predictive Check of Exposure-Response Modeling of Ordered Categorical Data Wednesday 14:15-14:35 |
B-13 Chee Ng Novel GPU-based Parallelized Qausi-random Parametric Expectation-Maximization (QRPEM) Estimation Method for Population Data Analysis Wednesday 14:35-14:55 |
B-14 Tea break, Poster and Software session II: Posters in Group II (with poster numbers starting with II-) are accompanied by their presenter Wednesday 14:55-16:10 |
B-15 Patanjali Ravva Covariate Modelling in Aggregate Data Meta Analysis: A Simulation Study Evaluating Performance of Model Linearization Wednesday 16:10-16:30 |
B-16 Marc Gastonguay Full Covariate Models as an Alternative to Methods Relying on Statistical Significance for Inferences about Covariate Effects: A Review of Methodology and 42 Case Studies. Wednesday 16:30-16:50 |
B-17 Celine M. Laffont How to analyse multiple ordinal scores in a clinical trial? Multivariate vs. univariate analysis. Wednesday 16:50-17:10 |
B-18 Julie Bertrand Some Alternatives to Likelihood ratio and Wald Tests for Pharmacogenetic studies using nonlinear mixed effect models. Wednesday 17:10-17:30 |
C-01 Abhishek Gulati Linking in silico and in vitro experiments to identify and evaluate a biomarker for enoxaparin activity Thursday 08:30-08:55 |
C-20 Joshua Pink Pharmacokinetic-pharmacodynamic-pharmacoeconomic analysis of rituximab for follicular lymphoma Thursday 08:55-09:20 |
C-21 Elodie Plan Modelling Techniques Handling Dynamic Pain Scores Characteristics Thursday 09:20-09:45 |
C-22 Presentation of Lewis Sheiner Student Session Awards Thursday 09:45-09:50 |
C-23 Coffee break, Poster and Software session III: Posters in Group I (with poster numbers starting with IIII-) are accompanied by their presenter Thursday 09:50-11:05 |
C-24 Malcolm Rowland Physiologically based pharmacokinetics: Advancing the clinical dimension Thursday 11:05-11:55 |
C-25 Ashley Strougo Scaling pharmacokinetics to estimate the “first dose in children”: comparing allometric scaling and PBPK Thursday 11:55-12:15 |
C-26 Lunch Thursday 12:15-13:45 |
C-27 Benjamin Ribba Evaluation of the antitumor effect of PCV chemotherapy on low-grade gliomas patients with a longitudinal tumor growth inhibition model Thursday 13:45-14:05 |
C-28 Emma Hansson PKPD Modeling of VEGF, sVEGFR-2, sVEGFR-3 and sKIT as Biomarkers of Tumor Response and Overall Survival Following Sunitinib Treatment in GIST Thursday 14:05-14:25 |
C-29 Ines Paule Individual Prediction-Based Dose Adaptation Of Capecitabine: In Silico Comparison With The Standard Method, Impact On Limiting Toxicity and On Antitimour Efficacy Thursday 14:25-14:45 |
C-30 Coen van Hasselt Optimizing monitoring strategies of trastuzumab induced cardiotoxicity: Development and application of a population pharmacodynamic model quantifying trastuzumab induced changes in cardiac function Thursday 14:45-15:05 |
C-31 Tea break, Poster and Software session IV: Posters in Group II (with poster numbers starting with IV-) are accompanied by their presenter Thursday 15:05-16:20 |
C-32 Lee Kien Foo Cost minimization of a phase II clinical study Thursday 16:20-16:40 |
C-33 Sebastian Ueckert Explicit Optimization of Clinical Trials for Statistical Power Thursday 16:40-17:00 |
C-34 Peter Gennemark Optimal design in population kinetic experiments by set-valued methods Thursday 17:00-17:20 |
C-35 Social Evening Thursday 20:00-01:00 |
D-01 Leonid Gibiansky Modeling of Drugs with Target-Mediated Disposition Friday 09:00-09:40 |
D-37 Stefaan Rossenu Population Pharmacokinetic/Pharmacodynamic Modeling of a New Antithrombotic Drug, The Nanobody® ALX-0081 Friday 09:40-10:00 |
D-38 Angelica Quartino An integrated G-CSF-myelosuppression model characterizing the target mediated disposition of endogenous G-CSF in breast cancer patients following chemotherapy Friday 10:00-10:20 |
D-39 Preview of PAGE 2012 Friday 10:20-10:30 |
D-40 Kyungsoo Park Preview of WCoP 2012 Friday 10:30-10:40 |
D-41 Coffee break Friday 10:40-11:10 |
D-42 Stephan Schmidt Coping with Time Scales in Disease Systems Analysis: Application to Bone Remodelling Friday 11:10-11:30 |
D-43 Elba Romero Coupling complex mechanistic PK/PD modelling with dynamic system analysis to obtain relevant clinical/biological insights. Application to gonadotropin hormone release agonist Friday 11:30-11:50 |
D-44 Wojciech Krzyzanski Solving Delay Differential Equations in S-ADAPT by Method of Steps Friday 11:50-12:10 |
D-45 S. Y. Amy Cheung Structural identifiability of parallel pharmacokinetic experiments as constrained systems Friday 12:10-12:30 |
D-46 Closing remarks Friday 12:30-12:40 |
D-47 Audience Input for the PAGE 2012 Program Friday 12:40-12:55 |